STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
70 hedge funds and large institutions have $116M invested in Stemline Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Holders
70
Holding in Top 10
–
Calls
$1.75M
Puts
$575K
Top Buyers
| 1 | +$1.79M | |
| 2 | +$1.38M | |
| 3 | +$1.16M | |
| 4 |
CCI
Columbus Circle Investors
|
+$1.15M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$1.13M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$1.95M | |
| 3 | -$1.92M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$944K |
| 5 |
Millennium Management
New York
|
-$788K |